Dr. Justin M. Gomez, MD

Dr. Gomez practices at Space Coast Endoscopy Center in Rockledge, Florida.

Dr. Gomez's NPI, 1215251038, was assigned on March 23, 2010. Dr. Gomez graduated from University Of Florida College Of Medicine in 2010. Dr. Gomez holds Florida license ME129860.

Dr. Gomez's primary practice is Space Coast Endoscopy Center, at 1974 Rockledge Blvd Suite 102, Rockledge, FL 32955. The practice phone is (321) 504-4440.

Dr. Gomez's primary practice is Space Coast Endoscopy Center in Rockledge, Florida. Dr. Gomez is also affiliated with Viera Hospital. The medical group on file is Florida Digestive Health Specialists. Dmand AI also links Dr. Gomez to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gomez practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Gomez's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Gomez is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Gomez's licenses on file in 2 states: Florida and Virginia.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver and gastroduodenitis among the conditions Dr. Gomez treats.

CMS data shows 1,002 Medicare services from Dr. Gomez across 11 procedure codes in 2024, for 595 Medicare patients. Medicare paid $115,527 for them.

CMS counts 595 Medicare patients who saw Dr. Gomez in 2024. The largest group is 65 to 74, with 315 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gomez's median patient age at 65, with 47% women.

In 2024, Dr. Gomez wrote 1,568 Medicare Part D claims for 597 patients. 81% of them were for generic drugs. CMS names the drug for 1,427 of them, across 25 drugs with 11 or more claims each, at $267,564 in total drug cost. In 2023, CMS named 1,249 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Gomez for performance year 2024, reported as part of a group. Dr. Gomez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gomez as offering telehealth. CMS counts 274 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Gomez, more than 94% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Gomez, published from 2007 to 2023. Dr. Gomez's most frequent co-authors are Wissam A. Bleibel, MD, Domenico Coppola, MD and Jeanetta W. Frye, MD.

Dmand AI links Dr. Gomez to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Choledocholithiasis and Common Bile Duct Diseases.

CMS Open Payments shows 278 general payments to Dr. Gomez from 20 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $2,657.

Dr. Gomez graduated from University Of Florida College Of Medicine in 2010.

Dr. Gomez is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.